1-4 of 4
Jaine Blayney
Close
Sort by
Journal Articles

UBASH3B knockout Downregulates STAT1 Mediated Interferon Signalling and Megakaryocyte Related Genes in a JAK2 V617F Positive MPN Model

Graeme M Greenfield, Deirdra Venney, Jaine Blayney, Mary Frances McMullin, Ken I Mills
Journal: Blood
Blood (2022) 140 (Supplement 1): 6752–6754.
https://doi.org/10.1182/blood-2022-167709
Published: 2022
Journal Articles

Enabling the Implementation of Next-Generation Sequencing into Clinical Diagnosis: Nemhesys Project

Jesús María Hernández-Rivas, Inmaculada Serramito-Gómez, Saara Kallio, Amparo Cantalejo, Jana Kotaskova, Ana E. Rodriguez, María Abáigar, Rocio Benito, Anna Dolnik, Mark Catherwood, Jaine Blayney, Boris Tichý, Ivana Chalupová, Philippe Dubois, Roberto Lopez, Carlos Barranquero, María Díaz Lorenzo, Mylène Leitzelman, Sadiksha Adhikari, Šárka Pospíšilová, Lars Bullinger, Ken I Mills, Caroline A. Heckman
Journal: Blood
Blood (2022) 140 (Supplement 1): 13122–13124.
https://doi.org/10.1182/blood-2022-163285
Published: 2022
Journal Articles

Application of Hallmarks of Cancer Gene Signatures Reveals Novel Energetics-Associated Subtypes with Distinct Survival Outcomes in AML

Paul Strain, Enya Scanlon, Gera Jellema, Richard Kennedy, Ken I Mills, Jaine Blayney
Journal: Blood
Blood (2022) 140 (Supplement 1): 11815–11816.
https://doi.org/10.1182/blood-2022-160171
Published: 2022
Journal Articles

Identifying Combination Therapies Targeting Apoptosis Pathways in Pediatric Acute Myeloid Leukemia (CAuSAL Study)

Katrina Lappin, PhD BSc, Kyle B Matchett, PhD, Jaine Blayney, PhD, Ken I Mills, PhD FRCPath, BSc
Journal: Blood
Blood (2018) 132 (Supplement 1): 2731.
https://doi.org/10.1182/blood-2018-99-111234
Published: 2018